$1.93
3.02% yesterday
Nasdaq, Apr 16, 10:00 pm CET
ISIN
US14757U1097
Symbol
CASI
Sector
Industry

CASI Pharmaceuticals Inc Target price 2025 - Analyst rating & recommendation

CASI Pharmaceuticals Inc Classifications & Recommendation:

Buy
100%

CASI Pharmaceuticals Inc Price Target

Target Price $4.00
Price $1.93
Potential
Number of Estimates 1
1 Analyst has issued a CASI Pharmaceuticals Inc price target 2026. The average CASI Pharmaceuticals Inc target price is $4.00. This is higher than the current stock price.
A rating was issued by 1 analysts: 1 Analysts recommend CASI Pharmaceuticals Inc to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the CASI Pharmaceuticals Inc stock has an average upside potential 2026 of . Most analysts recommend the CASI Pharmaceuticals Inc stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 28.54 18.82
15.76% 34.07%

1 Analyst has issued a sales forecast CASI Pharmaceuticals Inc 2025 . The average CASI Pharmaceuticals Inc sales estimate is

$18.8m
Unlock
. This is
34.07% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$18.8m 34.07%
Unlock
, the lowest is
$18.8m 34.07%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $28.5m 15.76%
2025
$18.8m 34.07%
Unlock
2026
$70.4m 273.89%
Unlock
2027
$89.5m 27.17%
Unlock
2028
$108m 20.80%
Unlock
2029
$11.2m 89.66%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
EV/Sales 1.91

Based on analysts' sales estimates for 2025, the CASI Pharmaceuticals Inc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.26 110.00%
2025
1.91 51.63%
Unlock
2026
1.32 30.92%
Unlock
2027
1.04 21.36%
Unlock
2028
0.86 17.23%
Unlock
2029
3.22 274.46%
Unlock

P/S ratio

Current 1.05 14.43%
2025
1.59 51.68%
Unlock
2026
1.24 22.08%
Unlock
2027
0.97 21.36%
Unlock
2028
0.81 17.22%
Unlock
2029
2.68 231.96%
Unlock

Current CASI Pharmaceuticals Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
HC Wainwright & Co.
Locked
Locked
Locked Apr 09 2025
Analyst Rating Date
Locked
HC Wainwright & Co.:
Locked
Locked
Apr 09 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today